SCHEMBL20240671

SCHEMBL20240671

NC1CCCN(C=CC=O)C1

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 1/20 0.31
PIM1 P11309 1/20 0.31
PIM3 Q86V86 1/20 0.31
PIM2 Q9P1W9 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18957514 1.00 CHRNA7 (0.31) CHRNA7PIM1PIM3PIM2
SCHEMBL2385755 0.79
SCHEMBL5101181 0.79
Hydrochloric Acid SCHEMBL31340503 0.77 PIM1 (0.33) CHRNA7PIM1PIM3PIM2
Hydrochloric Acid SCHEMBL22118548 0.75
SCHEMBL23970309 0.72
SCHEMBL14527947 0.72 MEN1 (0.36) CHRNA7PIM1PIM3PIM2
SCHEMBL4739305 0.72 CYP2D6 (0.37)
Hydrochloric Acid SCHEMBL31340824 0.71 MEN1 (0.35)
SCHEMBL644462 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018103058-A1 INHIBITORS OF BRUTON'S TYROSINE KINASE AND METHODS OF THEIR USE JANSSEN PHARMACEUTICA NV (BE) 2018-06-14 WO disclosed